Shifeng Yang
P.R. China
Hangzhou, 310022, China
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC.
Journal: Oncology letters
Published: August 30, 2022
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer.
Journal: Annals of translational medicine
Published: February 11, 2021
WNT/β-catenin pathway activation via Wnt1 overexpression and Axin1 downregulation correlates with cadherin-catenin complex disruption and increased lymph node involvement in micropapillary-predominant lung adenocarcinoma.
Journal: Journal of thoracic disease
Published: November 19, 2020
Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: October 18, 2020
Genomic alterations and survival in young patients aged under 40 years with completely resected non-small cell lung cancer.
Journal: Annals of translational medicine
Published: June 04, 2019
PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
Journal: BMC cancer
Published: December 13, 2018
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
Journal: BMC cancer
Published: October 23, 2017
Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma.
Journal: OncoTargets and therapy
Published: July 27, 2017
The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA.
Journal: Oncology letters
Published: July 25, 2017
Clinical and pathological findings of surgically resected patients for lung adenocarcinomas harboring uncommon EGFR mutations.
Journal: International journal of clinical and experimental pathology
Published: March 26, 2017
Last Updated: 09/26/2026